eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Special issues Abstracting and indexing Subscription
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
6/2010
vol. 6
 
Share:
Send email
Share:
abstract:

Clinical research
Long-term survival of endometrioid endometrial cancer patients

Leszek Gottwald
,
Piotr Pluta
,
Janusz Piekarski
,
Michał Spych
,
Katarzyna Hendzel
,
Katarzyna Topczewska-Tylinska
,
Dariusz Nejc
,
Robert Bibik
,
Jerzy Korczyński
,
Aleksandra Ciałkowska-Rysz

Arch Med Sci 2010; 6, 6: 937-944
DOI: https://doi.org/10.5114/aoms.2010.19305
Online publish date: 2010/12/29
View full text Get citation
 
Introduction : To establish risk factors for onset and progression of endometrioid endometrial cancer still remains the aim of scientists. The aim of the study was to determine disease-free survival (DFS) and overall survival (OS) in women with endometrioid endometrial cancer.

Material and methods : A retrospective review of 142 patients with endometrioid endometrial cancer after surgery treated with adjuvant radiotherapy and/or chemotherapy in the Regional Cancer Centre in Lodz between 2002 and 2004 was performed. Clinical and pathological data were correlated with clinical outcome and survival.

Results : In 3 patients (2.1%) clinical progression was diagnosed during the treatment. In 23 patients (16.7%) after primary remission, relapse was diagnosed 2-56 months after treatment. DFS and OS were 81.7% and 83.1% respectively. Better DFS significantly correlated with larger number of pregnancies (> 1), stage I of the disease and optimal surgery. Lower stage of disease, pelvic lymph node dissection, optimal surgery and depth of myometrial infiltration  50% were independent prognostic factors for better OS.

Conclusions : The results of our study provided significant evidence that early detection of endometrioid endometrial cancer enables optimal surgery. It reduces the indications for adjuvant therapy in stage I of the disease, and makes the prognosis significantly better. Other clinical and pathological factors such as numerous pregnancies, pelvic lymphadenectomy, and depth of myometrial infiltration, although important, are of less significance. Further prospective, randomized studies are necessary to prove the role of these factors.
keywords:

endometrioid endometrial cancer, prognostic factors, disease-free survival, overall survival
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.